<bill session="116" type="h" number="8139" updated="2020-11-11T04:46:25Z">
  <state datetime="2020-09-01">REFERRED</state>
  <status>
    <introduced datetime="2020-09-01"/>
  </status>
  <introduced datetime="2020-09-01"/>
  <titles>
    <title type="short" as="introduced">SUPPLIES Act of 2020</title>
    <title type="short" as="introduced">SUPPLIES Act of 2020</title>
    <title type="short" as="introduced">Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020</title>
    <title type="short" as="introduced">Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020</title>
    <title type="display">SUPPLIES Act of 2020</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to remove direct sales of drugs near expiration during the COVID-19 emergency from the calculation of certain pricing metrics under the Medicaid program.</title>
  </titles>
  <sponsor bioguide_id="B001257"/>
  <cosponsors>
    <cosponsor bioguide_id="S001200" joined="2020-09-01"/>
  </cosponsors>
  <actions>
    <action datetime="2020-09-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-09-01" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Home and outpatient care"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2020-09-01T04:00:00Z" status="Introduced in House">Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 or the SUPPLIES Act of 2020

This bill excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.</summary>
  <committee-reports/>
</bill>
